pyridostigmine bromide has been researched along with mycophenolic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habermann, TM; O'Neill, BP; Salomao, DR; Vernino, S | 1 |
| Lo, YL; Prakash, KM; Puvanendran, K; Ratnagopal, P | 1 |
| Bhagavati, S; Chari, G; Maccabee, PJ | 1 |
| Casassus-Buihle, D; Chauveau, E; Fraudin, A; Oddes, B; Reffet, A; Terrier, F | 1 |
| Chen, W; Chou, C; Lee, H; Su, K; Tsai, C | 1 |
| Badgley, BL; Cerda-Gonzalez, S; Dewey, CW; Fletcher, DJ; Harb-Hauser, MF; Levine, JM; Olby, NJ; Shelton, GD | 1 |
| Bopeththa, BVKM; Hewapathirana, HLI; Hewavithana, PB; Ralapanawa, U | 1 |
| Aban, I; Allman, PH; Burns, TM; Cutter, G; Duda, PW; Farzaneh-Far, R; Kaminski, HJ; Xin, H | 1 |
| Govindarajan, R; Singh, S | 1 |
| Abdelmeguid, A; Berry, GJ; Dewan, K; Rojansky, R | 1 |
1 review(s) available for pyridostigmine bromide and mycophenolic acid
| Article | Year |
|---|---|
Dysphagia and Dysphonia, a Pairing of Symptoms Caused by an Unusual Pair of Diseases: Castleman's Disease and Myasthenia Gravis.
Topics: Adolescent; Castleman Disease; Cholinesterase Inhibitors; Deglutition Disorders; Dysphonia; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Thymectomy; Tomography, X-Ray Computed; Velopharyngeal Insufficiency | 2021 |
9 other study(ies) available for pyridostigmine bromide and mycophenolic acid
| Article | Year |
|---|---|
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brain Neoplasms; Cell Transformation, Neoplastic; Drug Therapy, Combination; Female; Frontal Lobe; Humans; Immunity, Cellular; Immunosuppressive Agents; Lymphoma, B-Cell; Magnetic Resonance Imaging; Myasthenia Gravis; Mycophenolic Acid; Parietal Lobe; Prednisone; Pyridostigmine Bromide; Rituximab; T-Lymphocytes; Treatment Outcome | 2005 |
Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.
Topics: Adult; Aged; Cholinesterase Inhibitors; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Prednisolone; Pyridostigmine Bromide; Severity of Illness Index; Singapore | 2007 |
Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Brain; Cholinesterase Inhibitors; Electroencephalography; Epilepsy; Female; Humans; Immunoglobulins, Intravenous; Memory Disorders; Muscle Weakness; Muscle, Skeletal; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome | 2007 |
[Development of a myasthenia crisis during interferon treatment for chronic C hepatitis].
Topics: Aged; Antiviral Agents; Cholinesterase Inhibitors; Follow-Up Studies; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Male; Myasthenia Gravis; Mycophenolic Acid; Prednisone; Pyridostigmine Bromide; Ribavirin | 2007 |
Myasthenia gravis associated with lupus nephritis.
Topics: Cholinesterase Inhibitors; Fatal Outcome; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pyridostigmine Bromide; Siblings; Thymectomy; Young Adult | 2008 |
Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2008).
Topics: Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Inhibitors; Female; Immunosuppressive Agents; Male; Myasthenia Gravis; Mycophenolic Acid; Pyridostigmine Bromide; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Myasthenic crisis following iodinated contrast material (iohexol) aspiration: a case report.
Topics: Cholinesterase Inhibitors; Contrast Media; Deglutition Disorders; Disease Progression; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Iohexol; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pneumonia, Aspiration; Pneumothorax; Prednisolone; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Aspiration; Respiratory Insufficiency | 2019 |
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cholinesterase Inhibitors; Cross-Sectional Studies; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Pyridostigmine Bromide; Quality of Life; Registries | 2019 |
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
Topics: Adult; Betacoronavirus; Cholinesterase Inhibitors; Coronavirus Infections; COVID-19; Disease Progression; Female; Glucocorticoids; Humans; Hypercapnia; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Myasthenia Gravis; Mycophenolic Acid; Pandemics; Plasma Exchange; Pneumonia, Viral; Prednisone; Pyridostigmine Bromide; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Severity of Illness Index; Thymectomy; Tomography, X-Ray Computed | 2020 |